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Abstract
Background: The effect of a kidney transplant on a recipient extends beyond the restoration of kidney function.
However, there is limited qualitative analysis of recipient perspectives on life following transplantation, particularly
in the United States. To understand the full patient experience, it is necessary to understand recipient views on life
adjustments after kidney transplantation, medical management, and quality of life. This could lead to improvements
in recipient care and sense of well-being.
Methods: We conducted a paper-based survey from March 23 to October 1, 2015 of 476 kidney transplant recipients
at the University of Michigan Health System in Ann Arbor, Michigan. We analyzed their open-ended responses using
qualitative research methods. This is a companion analysis to a previous quantitative report on the closed-ended
responses to that survey.
Results: Common themes relating to changes following transplantation included: improvements in quality of life, a
return to normalcy, better health and more energy. Concerns included: duration of graft survival, fears about one day
returning to dialysis or needing to undergo another kidney transplant, comorbidities, future quality of life, and the cost
and quality of their healthcare. Many recipients were grateful for their transplant, but some were anxious about the
burdens transplantation placed on their loved ones.
Conclusions: While most recipients reported meaningful improvements in health and lifestyle after kidney transplantation,
a minority of participants experienced declines in energy or health status. Worries about how long the transplant will
function, future health, and cost and quality of healthcare are prevalent. Future research could study the effects
of providing additional information, programs, and interventions following transplantation that target these concerns.
This may better prepare and support kidney recipients and lead to improvements in the patient experience.
Keywords: Kidney transplantation, Grounded theory, Patient experience, Post-transplant expectations, Health-related
quality of life, Uncertainty, Cost, Comorbidities, Qualitative research
Background
Kidney transplantation has transformed the care of
patients with end-stage renal disease (ESRD). Each year,
approximately 17,600 kidney transplants are performed
within the United States (US), and currently 193,000
patients live with a functioning graft [1]. If the transplant
functions for at least 1 year, the median survival of the
kidney, depending on the donor type, is between 12 and
16 years [2]. Transplants can provide dramatic improve-
ments in quality of life and health status [3]. However,
improved outcomes are not universal [4], and most
patients are expected to eventually suffer graft loss [2].
Despite the large and growing population of kidney
transplant recipients, there is a limited understanding of
the subjective patient experience following transplan-
tation. A handful of qualitative studies have reported
recipient perspectives. These include Boaz and Morgan,
who interviewed kidney transplant recipients to study
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the return to normalcy, and Orr et al. who used focus
groups to understand quality of life [4, 5]. They found
that recipients define a normal life in a variety of ways
and reported common themes of fear, gratitude, and a
medicalization of their lives. While these teams spoke
with 26 and 25 patients respectively, a wider sample may
be better able to capture nuances of the post-transplant
experience. Howell et al. used focus-nominal groups to
study trade-offs between outcomes associated with im-
munosuppression [6]. They found that patients would
rather experience severe treatment-related adverse
events than lose their grafts, thereby illuminating the
importance of understanding and including the patient
perspective in clinical decision-making. Other studies in
this area have used closed-ended questions to study
patient experiences. Some compared life before and after
transplant [7–9] and found that prior to transplant
patients may overestimate gains in quality-of-life. One of
the few studies that included prompts about the future
was a follow-up of the Howell et al. qualitative analysis;
they asked patients to rank post-transplant outcomes
and found, supporting results from their earlier studies,
that patients ranked graft loss worse than death [6, 10].
While there are reports on recipient perspectives from
around the world (e.g., Europe [4, 5, 7]; Australia [6, 10];
Asia [11]; and Middle East [12]), there is little data on
experiences and future expectations of recipients within
the US. Experiences and interactions with healthcare
systems may be strongly affected by the context of care,
especially as it relates to cost and support systems.
This report is part of a larger study that seeks to
understand the perspectives of kidney transplant re-
cipients and their healthcare providers post-transplant.
An earlier paper compared patient and provider re-
sponses to closed-ended survey questions from the same
sample used in this analysis [13]. The objective of the
current paper is to draw themes from open-ended
responses about life changes, concerns about healthcare




This study was approved by the University of Michigan
(UM) Institutional Review Board (HUM00079279). The
survey instrument was designed based on two initial
focus groups (one with patients and one with providers).
Each had five participants. Both groups lasted 1 h and
included discussions about the post-transplant goals and
expectations of kidney recipients. An experienced quali-
tative researcher (SJG) facilitated these sessions. After
the survey was drafted, it was validated through two
cognitive interview sessions to determine whether the
participants understood the content of the questions.
One session included three patient participants and the
other five provider participants. The survey was revised
based on this feedback. Further detail on the survey de-
velopment and results from the closed-ended questions
are presented in Maass et al. [13].
Survey administration
The paper survey was administered between March 23
and October 1, 2015 to kidney transplant recipients and
providers. The survey included both closed- and
open-ended questions reflecting four main areas:
provider-patient relationships; general and transplant-re-
lated health; elements of clinical care; and affect and
well-being. The three open-ended response questions
were: “How has your life changed since having a kidney
transplant?”; “What concerns you most about your
health care and future quality of life?” and “Is there
something we didn’t ask you that you wish we had? If
so, please tell us what it is.”
To participate in the study, patients were required to
have had a primary kidney-only transplant at 18 years of
age or older at UM; to be at least 1 month post-trans-
plant; to have a currently functioning graft; and to not
have had transplants of any other organ nor an
additional kidney transplant prior to survey enrollment.
Kidney transplants may have come from either living or
deceased donors. Patients were recruited in-person
during regular follow-up visits to the UM transplant
center, a convenience sampling approach [14]. Each par-
ticipant could read and understand English and provided
written informed consent. Researchers were not present
while participants completed the survey. Family mem-
bers could have been in the room when the patient was
consented and began the survey, and providers may have
entered while participants were working on the survey.
Data analysis
Demographics and transplant-related data were collected
through retrospective chart review. Some demographic
data from this study have been published elsewhere [13].
Reporting of race and ethnicity conformed to US federal
guidelines [15, 16]. These data were used to compare
participants who responded to any of the open-ended
questions to those who left these questions blank. We
adapted the COREQ guidelines to a qualitative survey
analysis [17]. We report this alignment in Additional file 1.
Qualitative analysis
The analysis of the open-ended questions was conducted
using methods from the grounded theory framework
[18]. Themes of patient responses were developed
through cascading analysis of responses, rather than
through an a priori construct. In several steps, we itera-
tively reviewed patient responses and generated thematic
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categories based on the responses. After the final cod-
ing was completed, we combined categories into
major themes.
Specifically, we first selected a random sample of 30
responses for each of the three questions. Three research
staff members (ESG, HS, and SMC) each reviewed the
responses for two of the three open-ended questions
and developed initial response categories.
Next, the three research staff members reviewed all of
the responses to the open-ended questions and identi-
fied additional response categories. The project team
reviewed the revised list of categories, and the team
combined overlapping categories to produce a prelimi-
nary list of ten, nine, and six categories for each
question, respectively.
Using the preliminary lists of categories, all of the
responses were coded (0 or 1) in Microsoft Excel to
record whether they corresponded to each category,
where 0 indicated no, and 1 indicated yes [19, 20].
Categories were not mutually exclusive; a response could
correspond to multiple categories. Each question was
coded by two independent reviewers (ESG, HS, SMC, or
ELT), and inter-coder reliability was assessed at 94% or
higher. During the coding process, new categories were
proposed for each of the questions. After further team
discussion, the new list of categories included 13, 11,
and 13 categories for each question, respectively.
The responses to each of the questions were next
re-coded according to the new list of categories. Each
question was coded by two independent reviewers (HS,
SMC, or ELT). No further categories were proposed, and
the categorization was considered to have reached
saturation [21, 22]. Initial discrepancies between coded
responses were resolved through review by a researcher
not involved with the coding (KLM). Where there was
further uncertainty, discrepancies were resolved through
consensus between two team members (KLM and ELT).
Researchers (ESG, HS, SMC, and ELT) then identified
representative quotations for each category for each
question. Through a team discussion and review of
the quotations, the categories were synthesized into a
smaller number of overarching themes for a total of
6, 6, and 4 themes for each of the three questions,
respectively. Participants did not provide feedback on
the findings.
Results
The response rate to the full survey was 66%, and demo-
graphic characteristics were similar between those who
consented and those who declined to participate. Partici-
pants in the survey were older, transplanted more
recently, more likely to be male and have received a
living unrelated donor transplant compared to the UM
kidney transplant population that met eligibility for the
study. A comparison of the demographic characteristics
of participants who responded to the open-ended ques-
tions to those who did not is shown in Table 1. Partici-
pants who answered the open-ended questions versus
those who did not were younger at the time of trans-
plant (mean age 48.3 vs. 52.0, p = 0.05), were more likely
to be female (37% vs. 23%, p = 0.05), and were trans-
planted more recently (median years since transplant
5.1 vs. 8.0, p = 0.02).
Life changes post-transplant
In the first question, patients were asked: “How has your
life changed since having a kidney transplant?” Six
themes were identified from the 414 responses. Themes
included improved quality of life and return to normalcy
(n = 197); better health and more energy (n = 69); grati-
tude and sense of purpose or freedom (n = 55); burdens
of post-transplant regimens (n = 37); no change (n = 30);
Table 1 Survey participant demographics by free response
status






Age at Transplant (mean [SD]) 48.33 (13.57) 51.96 (11.75)
18–35 (% [n]) 20% (84) 10% (5)
35–50 (% [n]) 34% (148) 35% (17)
50–65 (% [n]) 36% (154) 40% (19)
65–77 (% [n]) 10% (42) 15% (7)
Gender % (n)
Female 37% (160) 23% (11)
Male 63% (268) 77% (37)
Race % (n)
White 77% (325) 79% (37)
Black 18% (76) 19% (9)
Asian 2% (10) 2% (1)
Other 3% (13) 0% (0)
Ethnicity % (n)
Non-Hispanic 96% (390) 100% (47)
Hispanic 4% (15) 0% (0)
Donor Type % (n)
Living Related 30% (128) 25% (12)
Living Unrelated 29% (126) 27% (13)
Deceased 41% (174) 48% (23)
Years Post-transplant on
10/1/2015 (median [IQR])
5.11 (2–9) 7.95 (3–11)
0.1–3 (% [n]) 34% (144) 21% (10)
3–5 (% [n]) 15% (65) 13% (6)
5–10 (% [n]) 30% (128) 35% (17)
10–31 (% [n]) 21% (91) 31% (15)
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and worsened and less energy (n = 23). These themes are
reported in Table 2, and examples of responses are
provided in Table 3. Thirty-nine patients wrote “yes”
without further qualification. As it was unclear whether
those changes were positive or negative, those 39
responses were not further analyzed.
Improved quality of life and return to normalcy
The most common change noted after a kidney trans-
plant was an improvement in quality of life and a return
to normalcy. For many, no longer attending dialysis
clinic multiple days per week allowed them to, as one
patient wrote, “have a daily schedule” and as another
patient wrote, have a “routine daily life.” Some reported
that they have the time post-transplant to work, spend
time with their families, and conduct tasks of daily
living. Many patients also could use this time in new
ways because they felt better, describing it as “I now
have a life. I can participate in activities that I couldn’t
before.” This led to a strong sense of normalcy for some;
e.g., “I am able to feel human and alive again” which
may in turn have caused the stress of their pre-trans-
plant lives to fade. As one patient wrote: “happy to not
be hooked up to dialysis anymore almost to a point I
forget I ever was.”
The enthusiasm expressed in the survey responses var-
ied, but many conveyed strong emotion. This was
expressed in intense punctuation, “No more dialysis!!
Wonderful!!” and phrases written in all capital letters: “I
CAN SEE RETIREMENT!!” Even in more muted
responses, e.g., “It has been much better. I am happy I
got it”, the change was evident. In writing about the
extremes of pre-transplant life, some patients may have
used hyperbole to show a dramatic contrast with their
post-transplant lives, e.g., “not doing dialysis 10 hours
per day.”
Better health and more energy
Many patients reported improvements in their health.
Some of these responses were particularly strong; e.g., “I
feel awesome!!” and “having health restored is an in-
credible experience.” However, some of the subdued
responses also affirmed the substantial improvement that
can occur after a transplant; e.g., “overall better health”
and “I feel better all over.” One patient reported “not sick
daily,” and another wrote “feel well the majority of the
time.” Many also commented on increased energy.
Gratitude and sense of purpose and freedom
Recipients discussed the relief they felt from the burdens
of renal failure and dialysis. One patient wrote “enjoy
even the small things, feel blessed,” and another reported
“every single day is a gift.” Many participants specifically
mentioned feeling an increased sense of freedom, e.g.,
“feel better and free.” This was often presented in the
context of no longer having regular dialysis visits, e.g.,
“able to travel without the formality of finding a clinic to
dialyze in while out of state” and “no sense of doom.”
Another patient reported that “it [the transplant] has
been the most wonderful gift I have ever gotten. It has
given me back my freedom to travel.” Some mentioned a
new sense of conviction. One felt “more purposeful,”
and another reported, “it [their life] has become full of
more purpose. I feel I have been given a 2nd chance.” A
recipient reported “being in control of my destiny.”
Patients also noted a greater sense of hopefulness; one
reported “optimism,” another commented “more positive,”
Table 2 Themes from patient responses by questiona






Q13: How has your life changed
since having a kidney transplant?
414
Improved quality of life and return
to normalcy
197 48%
Better health and more energy 69 17%
Gratitude and corresponding






No change 30 7%
Worsened and less energy 23 6%
Q14: What concerns you most about
your healthcare and future quality
of life?
383
Comorbidities and quality of life 162 42%
Kidney-related health issues 121 32%
Quality and cost of healthcare 84 22%
No concerns 40 10%
Family and support systems 24 6%
Lifestyle changes including less
energy
22 6%
Q15: Is there something we didn’t
ask you that you wish we had?
171
No 115 67%





Future of care and anxiety about
health
5 3%
aPatients who did not express a particular theme did not necessarily disagree
with the theme
bPatients were counted in each category they contributed responses to, so
some patients are counted more than once
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and a third wrote they are “thankful for each day, life
is short.”
Burdens of post-transplant regimens
Patients also reported undesirable changes to their lives
after transplantation. Often these were related to medi-
cations. Recipients take medications at least twice daily
to prevent rejection and to treat comorbidities. Some
patients were matter-of-fact, e.g., “lots of meds” and “just
taking more pills.” Others alluded to the burden of the
required medication; e.g., “it’s a hassle to take meds
every 12 hours” and “continuously taking meds.” For
some, changes in medication defined their post-trans-
plant experience. A recipient wrote that “The only
change has been the medication regimen. Over the term
to date of my transplant I have taken more than 85,000
pills.” Others mentioned the dietary restrictions that can
be added after a transplant, including as one wrote “not
eating what I want.”
No change
Some patients reported that they did not experience
substantial changes after receiving a transplant. Many of
Table 3 Representative responses to the first open-ended
questiona
Patient Responses by Theme
Improved quality of life and return to normalcy
“Better by far then dialysis, I can have a daily schedule.”
“More freedom/time (no dialysis), able to work and return to routine
daily life.”
“I can work now without missing much of it because of dialysis”
“Back to work not as tired.”
“I am able to do more things with my family”
“I feel better. No more dialysis. Looking forward to doing things I
couldn’t do.”
“It has been much better. I am happy I got it.”
“I now have a life. I can participate in activities that I couldn’t before.
Even with many med I feel great.”
“I am able to feel human and alive again”
“Happy to not be hooked up to dialysis anymore almost to a point I
forget I ever was.”
“No more dialysis!! Wonderful!!”
“Alive, alert, rested, peaceful, engaged in my tasks, much more
positive outlook, paying more attention to overall health. I CAN SEE
RETIREMENT!!”
“Not doing dialysis 10 h per day, taking more meds, more free time.”
Better health and more energy
“I have been extremely healthy physically for 12 years now. So having
health restored is an incredible experience. I appreciate life more.”
“I feel awesome!!”
“Overall better health + optimism”
“I feel better all over. A feeling of well-being.”
“More energy, clearer thinking, not sick daily, brighter outlook on life,
happier”
“I feel well the majority of the time”
“More energy. Feel active. A normal active life.”
“More energy + my outlook is more positive.”
Gratitude and corresponding sense of purpose or freedom
“I live life, enjoy even the small things, feel blessed.”
“Every single day is a gift”
“more freedom (dialysis)”
“Freedom to travel. Being in control of my destiny.”
“More freedom but also more health problem (diabetes) type 2”
“Feel better and free.”
“Being able to travel without the formality of finding a clinic to
dialyze in while out of state”
“more time (no dialysis), no sense of doom.”
“It has been the most wonderful gift I have ever gotten. It has given
me back my freedom to travel.”
“more purposeful, more appreciation.”
“It has become full of more purpose. I feel I have been given a 2nd
chance.”
“More energy + my outlook is more positive.”
Table 3 Representative responses to the first open-ended
questiona (Continued)
Patient Responses by Theme
“due to meds I am hospitalized 3–5 times a year. Moody. Able to
travel some. Thankful for each day, life is short.”
Burdens of post-transplant regimens
“Lots of meds”
“Just taking more pills”
“Quality of life is little changed, but it’s a hassle to take meds
every 12 h.”
“Not eating what I want continuously taking meds; feeling tired;
afraid of losing my kidney.”
“The only change has been the medication regimen. Over the term
to date of my transplant I have taken more than 85,000 pills”
Worsened and less energy
“No pep, tired”
“Have slowed down, not as much energy. Sometimes just don’t care”
“More stressful”
“Radical Changes, Unable to work due to secondary problems from
ESRD & Diabetes”
“Yes, other conditions worse.”
No Change
“No”
“It has not changed”
“Not much”
“Very little”
aThe first question was “how has your life changed since having a kidney
transplant?” Responses have been lightly edited to correct spelling errors
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these responses were simply “no.” Another recipient
wrote “it has not changed,” and others reported “very
little” or “not much.”
Worsened and less energy
Finally, some patients reported having less energy,
describing it as “no pep” and “have slowed down…
sometimes just don’t care.” They also reported instances
of poor transplant outcomes, many of which were
related to comorbidities. One patient wrote “radical
changes” and that he or she is “unable to work due to
secondary problems from ESRD & Diabetes.” Another
reported “other conditions worse.”
Concerns about their healthcare and future quality of life
The second open-ended question asked: “What concerns
you most about your health care and future quality of
life?” Three hundred eighty-three patients responded,
and six themes were identified: kidney-related health
issues (n = 121); comorbidities and quality of life (n =
162); quality and cost of healthcare (n = 84); no con-
cerns (n = 40); family and support systems (n = 24);
and lifestyle changes including less energy (n = 22).
These themes are reported in Table 2, and examples
of patient responses are provided in Table 4.
Kidney-related health issues
Patients expressed concerns about kidney failure and
how long their transplants will last. Several responses
were variants of “failure of the transplant.” However, for
some, the concern was not if graft loss would occur but
rather when. One reported the “fear of future unknown,
how long will my kidney last,” and another wrote “not
knowing how long my kidney will perform and if my
health will deteriorate again.” Patients also expressed
concerns about what would happen after their transplant
failed. Many commented specifically on returning to
dialysis, including “having to go on dialysis once this
kidney loses function”, and “never want dialysis again.”
Others were concerned about a second transplant, e.g.,
“be able to receive another transplant when needed.”
Comorbidities and quality of life
A predominant concern was for comorbidities related to
kidney disease and quality of life. Patients often noted a
particular comorbidity that they either currently have or
could develop in the future. Many answered solely
“diabetes.” Other conditions mentioned included high
blood pressure, pain, cancer, recurrent urinary tract
infections, and heart disease. Patients also described
symptoms, e.g., “pain, numbness, balance, and coldness.”
A large portion of participants reported improvements
in their quality of life in the first open-ended question,
and many used this space to express concerns about
maintaining it. Several responses were close variants of
“staying healthy,” and one recipient wrote he or she
wanted to “continue to live an active high quality life.”
Another responded: “to be able to do the things I did
before. Do stuff with my grandchildren and friends.
Hang out laundry outside, go where I want to go.”
Another included the concern of “being able to do what
I want without pain.” Others expressed concern about
the risk of hospitalization, e.g., one reported “never
know when I will go back in the hospital (frustrating).”
Quality and cost of healthcare
Some of the strongest responses were related to the af-
fordability of post-transplant care. The exclamation of
one patient – “COST!!!!” – may reflect the strain that
transplant-related financial difficulties can place on pa-
tients and their families. Frequent responses within this
theme were short variants of “the cost.” Another patient
wondered rhetorically: “How much all of it will cost?!”
Financing, including insurance, was another worry; e.g.,
“insurance, insurance, insurance.” Responses included
“rejection of insurance,” “losing my health insurance,”
and “insurance and its possible disruption to the best
healthcare.”
Others were concerned about the quality of their
healthcare. One noted “I just want the future level of
care to continue as it is at present,” and another re-
cognized potential changes in the long-term: “how will
my health care be different in 10 to 20 years.”
Family and support system
Participants also commented on the significant impacts
a transplant can have on family structure and roles.
These responses were often imbued with emotion, and
some expressed concern about how their future care
would affect their families; e.g., “I know my transplanted
kidney will not last forever. So I’m most concerned
about getting sick again and going through dialysis and
another surgery and the impacts it will have on my fam-
ily now that I have a child.” A few mentioned the possi-
bility of becoming a burden; e.g., “I do not wish to
become a burden on my family,” and another said, “I’m
sure they [his/her grown children] would like to move
out & have a normal life but feel quite guilty trying to
help take care of me & help with all the bills.” One
reported the concern “being taken care of.” Other patients
were concerned about the opposite role - being able to
support their families, e.g., “not being there for my family”
and “not being able to take care of my family.”
Lifestyle changes including less energy
Patients also mentioned concerns related to lifestyle
changes. Some noted the desire to be more mobile, e.g.,
“getting to walk again” or have more energy, such as
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“wish I had more energy.” Others were concerned with
their ability to work; one wondered “How will my fi-
nances be managed in the future if my transplant kidney
fails and I cannot work as [a] mechanic?”
Additional topics
The final open-ended question asked: “Is there something
we didn’t ask you that you wish we had? If so, please tell
us what it is.” One hundred seventy-one patients
responded. Most respondents wrote “no” (n = 115), indi-
cating that they did not have anything to add. Of the
patients who included additional comments, four themes
were identified: post-transplant care (n = 17); more com-
munication and information (n = 11); medications (n = 7);
and future of care and anxiety about their health (n = 5).
These themes are reported in Table 2, and additional
examples of responses are provided in Table 5.
Many of these themes overlap with previous questions
or report an individual recipient’s concern with their
own care. Notably, some wished for more information
from their providers and more communication. One
patient wrote: “didn’t explain all the after effects in
results of transplant,” and another reported “there is
Table 4 Representative responses to the second open-ended
questiona
Patient Responses by Theme
Kidney-related health issues
“concerned about kidney failure”
“Rejection or failure of the transplant.”
“Possible kidney rejection”
“One day I know my transplant will fail”
“fear of future unknown, how long will my kidney last rejection”
“How long will kidney last”
“How long will transplanted kidney last and what will happen to
health then.”
“Having to go on dialysis once this kidney loses function”
“Never want dialysis again”
“That I will be able to function and feel good when I am 20+ years
older. Also, that I will be able to receive another transplant when
needed.”
Comorbidities and quality of life
“diabetes”
“Blood Pressure & Diabetes”
“That my Lupus will flare up and cause me to decline or kill my
kidney.”
“Feet pain due to neuropathy”
“Cancer & Heart Disease”
“Skin cancer due to transplant”
“Multiple skin cancers”
“That I’m going to die with cancer in my stomach”
“repeat UTIs”
“Heart disease - wish I had more energy.”
“pain, numbness, balance, and coldness”
“Function on my own and continue to be healthy”
“stay healthy”
“continue to live an active high quality life”
“to be able to do the things I did before. Do stuff with my
grandchildren and friends. Hang out laundry outside, go where I
want to go”
“Staying healthy and not being a burden to others. Being able to do
what I want without pain.”
“diabetes, fatigue, not being able to work-I never know when I will go
back in the hospital (frustrating)”
Quality and cost of healthcare
“COST!!!!”
“How much all of it will cost?!”
“the cost”
“Insurance, insurance, insurance. Extremely important that I get
excellent insurance to cover all my meds to the end of my life, which
will be over 100 years young.”
“Rejection of insurance”
“Losing my health insurance.”
“Insurance and its possible disruption to the best healthcare.”
Table 4 Representative responses to the second open-ended
questiona (Continued)
Patient Responses by Theme
“I just want the future level of care to continue as it is at present”
“My concerns are the cost of health care, what quality of health care
will be provided in the future, what will my options be choosing
concerning the health care, how will my health care be different in
10 to 20 years”
Family and support systems
“I do not wish to become a burden on my family”
“My children are grown now (22 yrs. & 20 yrs). It has been 7 yrs. since
my transplant and I’m sure they would like to move out & live a
normal life but feel quite guilty trying to help take care of me & help
with all the bills.”
“I know my transplanted kidney will not last forever. So I’m most
concerned about getting sick again and going through dialysis and
another surgery and the impacts it will have on my family now that I
have a child.”
“Being taken care of”
Lifestyle changes including less energy
“Being mobile and able to take care of myself.”
“Getting to walk again.”
“Heart disease - wish I had more energy.”
“How will my finances be managed in the future if my transplant
kidney fails and I cannot work as [a] mechanic?”
“I worry that I will be able to work until I am at retirement age”
“I hope not to have issues in the future. My schooling and career are
important for me to finish/figure out.”
aThe second question was: “what concerns you most about your healthcare
and future quality of life?” Responses have been lightly edited to correct
spelling errors
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often no concern at the hospital… about my poor
immune system and right dosage of my medication
(and not listening to my correction and causing
invalid blood count).”
Discussion
This analysis provides a broad view of the patient
experience following kidney transplantation. Questions
prompted recipients to consider how their lives had
changed and their concerns about their healthcare and
quality of life. Many themes emerged from the
responses, including experiencing higher quality of life
and better health since transplantation as well as
concerns about future health, costs, and burdens of
care. These themes echo and extend results from
studies of kidney transplant recipients in other
contexts [3–6, 8, 10, 11].
Our results suggest that patients have disparate experi-
ences post-transplant. When asked “How has your life
changed since having a kidney transplant?”, the largest
portion of patients reported improvements in quality of
life and health, while several reported that there had
been no change, and some said their lives had worsened.
This is consistent with Orr et al. ([4] citing Orr A: “Pa-
tient attitudes to renal transplantation and quality of life
following renal transplantation: an exploratory study,”
unpublished)— who found that 15% of transplant pa-
tients experienced difficulties—and other studies that
have reported improvements [3, 24]. Similarly, prior
studies have reported different results for changes in en-
ergy level; some have seen increases [3, 8], and others
have reported decreases [5, 11, 23]. Patient responses in
this study lend credence to the finding that energy levels
after kidney transplantation vary between recipients.
Similarly, participants reported a variety of common co-
morbidities including diabetes, cancer, and heart disease
[6], though these do not affect all patients.
In addition, while many patients expressed the desire
for a normal life, patients may have different views on
what a “normal life” is. Some recipients mentioned that
they have returned to work. Others reported that they
were better able to care for themselves and others,
travel, and spend time with their families. While pro-
viders may consider returning to work an important
metric for transplant success [23, 25–27], the range of
responses indicate that patients may define normalcy
more broadly [5].
The effects of a kidney transplant are not limited to a
patient’s physical health or lifestyle; it can also have
substantial psychological benefits. Patients expressed
feeling a heightened sense of purpose and gratitude to
be alive. For many, this manifested itself in an increased
sense of freedom. While Smith et al. did not find statis-
tically significant differences in the amount patients
traveled pre- vs. post-transplant [8], recipients can travel
without having to make cumbersome dialysis arrange-
ments to maintain their dialysis regimes while away from
their customary dialysis facilities. The optimism may also
be derived from how much better many patients feel. As
their health improves, it is perhaps natural to foresee the
trajectory of their lives improving as well.
However, some patients also expressed a psychological
weight from changes post-transplant. A large portion
reported concerns regarding the potential for graft
failure. Past studies that have asked patients to rank pos-
sible transplant outcomes found that patients considered
graft failure worse than death [6, 10] and that the risk of
graft loss is a persistent fear [5]. Our study adds to past
literature in that it expands on why graft failure is
concerning. Patients reported stress related to the
uncertainty about when the failure would occur and the
implications for life afterwards. The anxiety about
returning to dialysis may be due to both the physical toll
and the potential burden on their support systems.
Furthermore, some patients expressed an obligation to
live a life of purpose because of the gift of the transplant;
this echoes a prior study that reported some patients felt
a duty to care for their kidney [4].
We see a resonance in many of the patient pers-
pectives with other studies conducted with patients
outside of the US [4–6, 10, 11]. This lends support to
the sense that the themes of quality of life and health
Table 5 Representative responses to the third open-ended
questiona
Patient Responses by Theme
Post-transplant care
“You have answered all the questions and I felt comfortable, life has
been a blessing and my kidney doctors have done a great job. Keep
up the good work.”
“How is the scheduling, wait times, value for wait times (i.e. is it worth
waiting for 1.5 h to see someone from 10 mins and then the travel
times etc.) Perception of true health care or is it more of a billing
opportunity”
More communication and information
“Didn’t explain all the after effects in results of transplant. Weight
gain, eating too much (prednisone) heart problems maybe, etc.”
“There is often no concern at the hospital (when hospitalized) about
my poor immune system and right dosage of my medication. (and
not listening to my correction and causing invalid blood count.)”
Medications
“Being able to afford my meds”
Future of care and anxiety about health
“Having a transplant introduces some insecurity in that future health
is uncertain as if it is very dependent on graft survival and graft
function. I have been extremely fortunate in maintaining my graft for
over 17 years- which I consider a near miracle.”
a The third open-ended question was: “is there something we didn’t ask you
that you wish we had?” Responses have been lightly edited to correct
spelling errors
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post-transplant and views on graft failure and living a life
of purpose may be experienced broadly.
In contrast, other prominent concerns included cost
and insurance, which may be more important within the
US context. These were among the strongest responses,
perhaps because they threaten both quality of life and
health. In particular, some of these concerns may relate
to the US payment system for immunosuppressant med-
ications. After a kidney transplant, Medicare pays for the
immunosuppressant medications for the first 3 years but
not after that time (unless the patient qualifies for Medi-
care via age or disability). Medications that are not cov-
ered by insurance can cost thousands of dollars out of
pocket annually [28, 29]. Patients also expressed specific
concerns about insurance. This may affect how patients
evaluate the decision to return to work; e.g., patients
may be unlikely to work part-time if it would lead to a
loss of government benefits. In the time since the survey
was conducted (2015), public policy in the US regarding
healthcare funding and insurance availability for those
with preexisting conditions has been volatile. This may
further exacerbate feelings of insecurity related to costs.
Our study is among the few to use qualitative methods
to study kidney transplant recipients within the US
context and to examine expectations for the future.
Much of the qualitative research about life after a kidney
transplant has been conducted through focus groups
and interviews, in contrast to in-person surveys. Our
study sample was recruited during follow-up visits and
included a broad range of patient demographics and
times since transplant; it is possible that a wider range of
patients participated than those who would have
attended more time-intensive focus groups.
The study’s limitations should also be considered. In
contrast to studies that use interviews and focus groups,
the survey was not interactive. As such, we could not ask
patients for clarification or for additional detail. We there-
fore must be particularly careful with interpretation and
be aware of a negativity bias. The open-ended questions
were asked at the end of the survey; responses may have
been influenced by earlier survey questions or survey
fatigue. Not all participants responded to the three
open-ended questions; 87, 80, and 36% of the participants
answered the questions, respectively. The study was
conducted at a single center, and it should be noted that
the exclusion criteria barred children and patients with
non-renal or prior renal transplants from participation, so
responses may not fully generalize to the full spectrum of
kidney transplant recipients. Patient responses were col-
lected in 2015 and may be less applicable in today’s con-
text. Perspectives, particularly those related to insurance
and the cost of post-transplant care, may also not be
representative of patient concerns outside of the US.
Finally, the counts presented in Table 2 should be viewed
cautiously. A lack of response does not imply that the
patient agreed or did not agree with a theme.
Conclusions
In this follow-on study, we use qualitative methods to
analyze the perspectives of kidney transplant recipients
about their current experiences and future concerns.
Common themes in the responses included improve-
ments in quality of life and health, as well as concerns
about remaining healthy, future quality of life, and cost.
Further study may be helpful to understand the effects
of cost on patient care and experiences. The findings
also suggest the need to study whether changes in
education and practice could lessen the stress related to
uncertainty in transplant outcomes. A better under-
standing of recipient perceptions based upon insights
gained from qualitative studies of recipient experiences
may lead to improvements in pre-transplant education
and in post-transplant care.
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